127 related articles for article (PubMed ID: 1741214)
21. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
[TBL] [Abstract][Full Text] [Related]
22. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
[TBL] [Abstract][Full Text] [Related]
23. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
24. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
Rogol AD; Blethen SL; Sy JP; Veldhuis JD
Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
[TBL] [Abstract][Full Text] [Related]
25. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
[TBL] [Abstract][Full Text] [Related]
26. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
Lanes R; Jakubowicz S
J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition.
Touati G; Prieur AM; Ruiz JC; Noel M; Czernichow P
J Clin Endocrinol Metab; 1998 Feb; 83(2):403-9. PubMed ID: 9467548
[TBL] [Abstract][Full Text] [Related]
29. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
[TBL] [Abstract][Full Text] [Related]
30. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
[TBL] [Abstract][Full Text] [Related]
31. Rate of change (modulation) of serum growth hormone concentrations is a more important factor in determining growth rate than duration of exposure.
Hindmarsh PC; Matthews DR; Stratton I; Pringle PJ; Brook CG
Clin Endocrinol (Oxf); 1992 Feb; 36(2):165-70. PubMed ID: 1568348
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
Liu HJ; Wang LH; Chen L
Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
[TBL] [Abstract][Full Text] [Related]
33. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.
Neyzi O; Yordam N; Ocal G; Bundak R; Darendeliler F; Açikgöz E; Berberoğlu M; Günöz H; Saka N; Calikoğlu AS
Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826
[TBL] [Abstract][Full Text] [Related]
34. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
[TBL] [Abstract][Full Text] [Related]
35. Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone.
Giustina A; Bussi AR; Jacobello C; Wehrenberg WB
J Clin Endocrinol Metab; 1995 Jan; 80(1):122-9. PubMed ID: 7829600
[TBL] [Abstract][Full Text] [Related]
36. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
37. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.
Pihoker C; Badger TM; Reynolds GA; Bowers CY
J Endocrinol; 1997 Oct; 155(1):79-86. PubMed ID: 9390009
[TBL] [Abstract][Full Text] [Related]
38. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
[TBL] [Abstract][Full Text] [Related]
39. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
40. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
